ATR and non-small cell lung carcinoma: This phenomenon might be due to activation of the ATR-CHK1 pathway [34], as additional research has shown that HDAC6 depletion increases cisplatin-induced cytotoxicity by activating the ATR/CHK1 pathway in non-small cell lung cancer [35].